[Question] 503A — what am I missing here
Confession thread, sort of.
I went from 0.5mg to 12.5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 10 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.
So now I have sulphur burps I did not need and a data point I cannot interpret. Two lessons in one.
Posting it in the hope that somebody at week 18 reads it before doing the same thing.
best — the order this archive was captured in
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the 503A/503B distinction is load-bearing, do not blur it
The telehealth + compounding combo cost API source plus 3% markup. Not cheap but covered by insurance depending on state.
regulatory claims need a citation to the actual rule, not interpretation
Disagree but this is the good kind of wrong — it is specific enough to be checked.
Yeah, 503A and 503B are different regulatory animals.
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
This is correct. The shortage list does expire and the rules change.
no pharmacy referral codes, naming is fine, recruiting is not
Strongly agree. API source transparency matters.
Strongly agree.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
no pharmacy referral codes, naming is fine, recruiting is not
Did they tell you their API source or dodge the question?
503B compounding is different from 503A, different rules, different legality
the Poland situation is different from the US, different regulations
This is correct. The shortage list does expire and the rules change.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
What is the actual shortage list status right now?
regulatory claims need a citation to the actual rule, not interpretation
What is the actual shortage list status right now?
Disagree on that part. 95.1% and 96.2% on the same vial is normal.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
telehealth costs telehealth plus compounding markup, total varies
- 1This is correct. The shortage list does expire and the rules change.7 comments in this branch · started by u/burned_once_twice
- 2regulatory claims need a citation to the actual rule, not interpretation5 comments in this branch · started by u/mateusz_adebayo